DarioHealth Corp. Proceeds from Lines of Credit
DarioHealth Corp. (DRIO) reported Proceeds from Lines of Credit of $31.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-11
- DarioHealth Corp. proceeds from lines of credit for the quarter ending 2025-12-31 was $0.00.
- DarioHealth Corp. proceeds from lines of credit for the quarter ending 2025-09-30 was $0.00.
- DarioHealth Corp. proceeds from lines of credit for the quarter ending 2023-12-31 was $0.00.
- DarioHealth Corp. proceeds from lines of credit for the quarter ending 2023-09-30 was $0.00.
- DarioHealth Corp. proceeds from lines of credit for fiscal 2025 was $31.70M.
- DarioHealth Corp. proceeds from lines of credit for fiscal 2023 was $29.60M, a 24.46% increase from fiscal 2022.
- DarioHealth Corp. proceeds from lines of credit for fiscal 2022 was $23.79M.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 derived: sum of 2 quarters · filed 2026-03-19 | $31.70M 10-K · filed 2026-03-19 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $31.70M 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $31.70M 10-Q · filed 2026-08-11 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | $29.60M 10-K · filed 2025-03-10 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $29.60M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $29.60M 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $23.79M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $23.79M 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $23.79M 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |